Our novel, safe viral vector platform enables the fast generation of mono- or multivalent vaccines against infectious diseases and cancer. The application results in strong balanced B-/T-cell immune response without any adjuvant and without the necessity of vector virus multiplication. Multiple or prime-boost immunizations can be easily performed.
| Website | http://www.prime-vector-technologies.com |
| Employees | 5 (5 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+11 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Keywords | Viral Vector Technology, Vaccine Development, Immunotherapy, Gene Therapy, Vaccine Platform, Cancer Vaccines, Infectious Disease Vaccines, Immunology, Therapeutic Vaccines, Drug Delivery, Biotechnology, Pharmaceutical |
| Competitors | Apex Systems, Pioneering Technology Corp., Quantum Computing Inc., Data Analytics Corp, Eureka Technology Inc., DigitalSpace Corporation, TechForward Inc., Dynasty Innovations- Remodeling & Design, Tech Innovators Inc., NextGenTech5976 +15 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Prime Vector Technologies employee's phone or email?
Ralf Amann is the CEO of Prime Vector Technologies.
5 people are employed at Prime Vector Technologies.
Prime Vector Technologies is based in Tübingen, Baden-Württemberg.
The NAICS codes for Prime Vector Technologies are [32, 325].
The SIC codes for Prime Vector Technologies are [28, 283].